Related Experiment Videos
Lymphomatoid granulomatosis presenting as central neurogenic hyperventilation
Chest
|October 1, 1984
Summary
Lymphomatoid granulomatosis with central nervous system lymphoma caused severe hyperventilation. Treatment with prednisone and cyclophosphamide resolved the hyperventilation, indicating a link between the condition and respiratory symptoms.
Area of Science:
- Neurology
- Oncology
- Pulmonology
Background:
- Lymphomatoid granulomatosis is a rare lymphoproliferative disorder.
- Central nervous system involvement in lymphomatoid granulomatosis can lead to diverse neurological manifestations.
- Central neurogenic hyperventilation is a rare and severe respiratory disturbance.
Observation:
- A patient diagnosed with lymphomatoid granulomatosis and focal central nervous system lymphoma presented with severe central neurogenic hyperventilation.
- The hyperventilation was characterized by rapid, deep breathing.
- No other potential causes for the hyperventilation were identified.
Findings:
- The patient's severe central neurogenic hyperventilation significantly improved following treatment.
- Treatment consisted of prednisone and cyclophosphamide, targeting the lymphomatoid granulomatosis and CNS lymphoma.
- Resolution of hyperventilation correlated with the management of the underlying lymphoproliferative disorder.
Implications:
- This case highlights a potential association between lymphomatoid granulomatosis with CNS involvement and central neurogenic hyperventilation.
- Effective management of the underlying lymphoproliferative disease can lead to the resolution of severe respiratory symptoms.
- Further research may elucidate the mechanisms linking CNS lymphoma to respiratory control abnormalities.